Search
Now showing items 1-1 of 1
Development of Innovative Agents for the Treatment of Metabolic Diseases
(2022-05-10)
Elevated LDL cholesterol (LDL-C) is an established risk factor in cardiovascular disease, the
leading cause of death in the world. To date three main therapeutic strategies have been evaluated to
reduce circulating LDL-C ...

